|
New Data and Emerging Management Strategies for Migraine Headache
STATEMENT OF NEED
Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually every aspect of their lives, including personal relationships, reproductive choices, and productivity i... |
|
|
Applying Precision Medicine in BRAF V600E–Mutant Metastatic Colorectal Cancer
STATEMENT OF NEED
Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because colorectal cancer initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages (ACS, 2021).... |
|
|
Video Viewpoint Strategy Session: Optimizing Treatment and Functional Outcomes in Head and Neck Squamous Cell Carcinoma
Gain expert insight on emerging treatment approaches for patients with head and neck squamous cell carcinoma, incuding the safety and tolerabilty of emerging treatments, survivorship care, and much more. This activity is presented by leading experts, Barbara Burtness, MD, Professor of Medicine at Yale School of Medicine and Smilow Cancer Hospital, and Lynsey Teulings, NP, Nurse Practitioner at Yale School of Medicine and Smilow Cancer Hospital. Start the activity now.
STATEMENT OF NEED
H... |
|
|
Best Practices in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies
Explore best practices in the management of tumor lysis syndrome associated with emerging cancer therapies. This activity, presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center, will review plans to optimize prevention, recognition, and treatment, as well as discuss emerging therapies and monitoring strategies for patient care. Start the activity ... |
|
Embracing Novelty in HFrEF: Optimizing Outcomes in Patients with Symptomatic, High-Risk HF
This adaptive and interactive 3-part webcast series is targeted to cardiologists and primary care physicians, alongside their interprofessional heart failure care team of nurse practitioners (NPs) and physician assistants (PAs). Moderated by Dr. Muthu Vaduganathan, cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School, joined by Drs. Javed Butler, Michelle Kittleson, and Amulya Nagarur, each webcast will focus on exploring the different facets of HFrEF that lead ... |
|
Applying ADAURA in Practice: Implications For Early Stage EGFRM NSCLC
This educational initiative is targeted to medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists and molecular pathologists who are involved in diagnosis of early stage NSCLC that is surgically resectable with curative intent. In addition to examining the latest ADAURA trial data and the potential utility of adjuvant osimertinib in stage IB-IIIA EGFRm NSCLC, the practice-changing implications of these results will also be explored from a variety of perspectives with thr... |
|
|
Podcast: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer
In this episode of Oncology Data Advisor TM, learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Listen now!
STATEMENT OF NEED
Th... |
|
|
Video Viewpoint Strategy Session: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer
Learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Start the activity now!
STATEMENT OF NEED
There are an estimated 13,800 new c... |
|
|
Addressing Challenges in Diagnosis and Treatment of Low-Grade Upper Tract Urothelial Carcinoma
OVERVIEW
Upper tract urothelial carcinoma (UTUC) has many similarities to bladder carcinoma, but also some important differences. Join Dr. Seth Lerner, as he contrasts these 2 diseases, as well as important differences between low-grade and high-grade UTUC. Dr. Lerner highlights important considerations in the instruments, imaging, and biopsy techniques for diagnosing low-grade UTUC. Surgical options are considered, with a focus on patient selection for endoscopic nephron-sparing surgery. The... |
|
Clinical Diversity and Genetic Variation in Lysosomal Disorders
Explain the principles of Pathogenic Processes in LSDs.
Explain that lysosomal composition, shape, contents, numbers differ between cell types
and have an effect on disease expression.
Review the evolving understanding of lysosomal autophagy functions. |
|
|
Video ViewPoint Strategy Session: Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers
Gain expert insight and strategies for the management of anaplastic thyroid cancer including emerging data on immunotherapies, and treatment to manage adverse events. This activity is presented by leading experts, Jochen Lorch, MD, MSc, Director Thyroid Cancer Center, Dana-Farber Cancer Institute, and Carolyn Grande, CRNP, AOCNP®, Oncology Nurse Practitioner, Abramson Cancer Center.
STATEMENT OF NEED
Thyroid cancer is one of the most prevalent cancers in the United States. An estimated ... |
|
|
Metastatic Triple-Negative Breast Cancer: Applying Treatment Advances to Personalized Care
Sara A. Hurvitz, MD, FACP, Director of the Breast Cancer Clinical Trials Program at the David Geffen School of Medicine at UCLA, and a prominent authority on TNBC, provides perspectives on personalized care plans for patients with metastatic TNBC, efficacy and safety of emerging treatments, strategies to improve quality of life for patients with metastatic TNBC, and much more! Start the activity now!
STATEMENT OF NEED
With an estimated 284,200 new cases per year, breast cancer is the mo... |
|
|
Exploring Best Practices for Diagnosis and Management of Adult-Onset Stills Disease
Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medicati... |
|
|
Exploring Best Practices for Diagnosis and Management of Hypereosinophilic Syndrome
Hypereosinophilic syndromes (HESs) are a broad group of disorders that can lead to serious complications, including cardiovascular disease, cerebrovascular disease, and death. Due to their rarity, however, HESs are challenging to diagnose and treat. In this in-depth review, presented by Princess Ogbogu, MD, and developed in collaboration with Michael Wechsler, MD, MMSc, the wide-ranging presentations of HES will be reviewed, along with pathophysiology, classification, and acute and chronic man... |
|
|
Podcast: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma
Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now!
STATEMENT ... |
|
|
Video Viewpoint Strategy Session: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma
Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now!
STATEMENT ... |
|
Strategies for Successfully Diagnosing and Treating Tardive Dyskinesia: Enlisting the Help of Caregivers, Improving the Lives of Patients
At any given time, roughly 1 of every 4 patients taking antipsychotics experiences tardive dyskinesia (TD), a debilitating condition characterized by involuntary movements of the tongue, lips, face, trunk, and extremities. Fortunately, effective pharmacologic treatments for TD are now available. However, it can be challenging for clinicians to assess patients for TD, keep up to date on new agents, and create personalized treatment plans that facilitate long-term treatment success. In this acti... |
|
|
Emerging Treatment Strategies for Advanced Cholangiocarcinoma
This in-depth discussion, presented by Lipika Goyle, MD, Massachusetts General Hospital, will feature expert insights on emerging therapeutic treatments, recent discoveries on novel therapies, managing strategies for monitoring and managing adverse events, and much more! Start the activity now!
STATEMENT OF NEED
Cholangiocarcinoma, also known as bile duct cancer, is a rare malignancy originating in the epithelium of the bile duct. Accounting for only 3% of gastrointestinal tumors, it is ... |
|
|
Video Viewpoint Strategy Session: Advances in the Treatment of Relapsed/Refractory Immune Thrombocytopenia
Learn new advances in the treatment of relapsed or refractory immune thrombocytopenia, including treatment differentiation, efficacy and safety strategies, and much more. This activity features perspectives from two noted experts in the field, Dr. Keith McCrae, Director of Benign Hematology at the Cleveland Clinic Taussig Cancer Center; and Ms. Phyllis McKiernan, Advanced Practice Nurse in Blood & Marrow Stem Cell Transplantation at the John Theurer Cancer Center, Hackensack Meridian Health.
... |
|
|
Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 3 - Peripheral T-Cell Lymphoma
In the third segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD, Anderson Cancer Center, evaluates guideline recommendations for the management of peripheral T-cell lymphoma (PTCL), assesses emerging data on novel therapies, and applies strategies to optimize treatment experiences for patients. For more expert insights on aggressive non-hodgkin lymphoma, complete modules 2 and 3. Start the activity now!
Each year, 81,560 new cases of non-Hod... |
|
|
Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 2 - Mantel Cell Lymphoma
In the second segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, shares expert insights on guideline recommendations for optimizing individual patient care, efficacy and safety data, and strategies to manage adverse event for patients with advanced aggressive mantle cell lymphoma (MCL). For more expert insights on aggressive non-Hodgkin lymphoma, complete modules 1 and 3. Start the activity now!
Each year, 81,560 new c... |
|
|
Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 1 - Diffuse Large B-Cell Lymphoma
In the first segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, evaluates guideline recommendations for the management of patients with advanced diffuse large B-cell lymphoma (DLBCL). Learners will receive expert insight on assessing emerging data on novel therapies, strategies to manage adverse events, and optimizing treatment for patients with advanced DLBCL. Complete modules 2 and 3 for more in-depth knowledge of ag... |
|
|
Enhancing the Clinical Outcomes of Patients with Extensive–Stage Small Cell Lung Cancer
Anne Chiang, MD, PhD, Yale School of Medicine, a leading expert on small cell lung cancer, for an in-depth presentation on patient outcomes in extensive-small cell lung cancer. Dr. Chiang will present evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, managing adverse events, and much more! Start the activity now!
An estimated 228,820 new cases of lung cancer are reported in the United... |
|
|
New Perspectives on Diagnosis and Treatment of EGFR Exon 20 Insertion–NSCLC
Discover new developments in the diagnosis and treatment of EGFR exon-20 Insertion–Mutant NSCLC and assess emerging efficacy and safety data on novel targeted therapies. This activity features expert insights from Helena Yu, MD, Memorial Sloan Kettering Cancer Center, and Maria Arcila, MD, Memorial Sloan Kettering Cancer Center.
This activity is also available as a podcast.
An estimated 235,760 new cases of lung cancer are reported in the United States annually, and 131,880 people die... |
|
|
Current and Emerging Therapies for Lysosomal Storage Disease
This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available for other attendees. |
|
|
New Opportunities in Advanced KRAS Mutation-Positive NSCLC
In this CME/NCPD activity, D. Ross Camidge, MD, PhD, of the University of Colorado, and Beth Sandy, MSN, CRNP, OCN®, of the University of Pennsylvania, discuss novel treatments for advanced KRAS mutation-positive NSCLC and how to manage adverse events associated with small molecule inhibitors. Start now!
An estimated 228,820 new cases of lung cancer are reported in the United States annually, and 135,720 people die of the disease (ACS, 2020). Approximately 84% of cases are classified as... |
|
|
Meeting the Challenges in Management of Sickle Cell Disease
No longer a life-threatening disease, sickle cell disease (SCD) has become a chronic disease with life-threatening events that requires coordinated care by a multidisciplinary care team. Join Michael R. DeBaun, MD, MPH, and Collin Montgomery, APRN, as they discuss the acute and chronic complications experienced by individuals with SCD and the barriers they often encounter. The faculty offer real-world strategies for overcoming these barriers to improve the quality of life and other health outc... |
|
|
Update on Therapeutic Advances in T-Cell Lymphoma
Join Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, as he discusses guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based CME/NCPD activity!
STATEMENT OF NEED
Each year, 74,240 new cases of non-Hodgkin lymphoma are diagnosed and 19,940 people die of the disease (ACS, 2020). Among these cases, 12% to 15% are classified as peripheral T-cell l... |
|
|
Optimizing the Management of Moderate-to-Severe Atopic Dermatitis in Adult Patients
STATEMENT OF NEED
Atopic dermatitis is a severe form of eczema pathologically characterized by skin barrier disruption mediated by a type 2 helper T-cell immune response. The incidence of atopic dermatitis is high, estimated to be approximately 15% to 20% in children and 1% to 3% in adults worldwide (Avena-Woods, 2017). In addition to the hallmark clinical symptoms of eczema and intense pruritus, atopic dermatitis is associated with a substantial and multifaceted patient-reported burden tha... |
|
Assessing a Patient With Long COVID-19: An Interactive Case Scenario
In this interactive case, the physician recommends a series of assessments for your patient with Long-COVID symptoms. For each assessment, the user chooses the outcome to hear recommendations from the experts. |
|
|
TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic
In this webcast series, members of the DAP Health team review key data and discuss their real-world experiences providing care for persons living with HIV during the COVID-19 pandemic. DAP Health opened one of California’s first COVID-19 clinics and hotlines to offer screening, testing, and treatment.
Topics covered in this webcast series include:
COVID-19–Related Complications in Persons Living With HIV (PLWH);
COVID-19 Testing Strategies;
Home Care for PLWH Diagnosed With COVID-1... |
|
|
Update CME: Internal Medicine and Primary Care LiveStream Rebroadcast June 2022
This conference (7.30 a.m. June 23 - 1.15 p.m. June 26) is organized by the American Medical Forum. Eminent speakers from The University of Chicago, Rush University, and Northwestern University will present the most advanced clinical guidelines. The course also offers live Q&A, and each speaker will take the time to answer your questions. At the conclusion, participants will be able to incorporate the most up-to-date treatment strategies to general chronic medical conditions implemented in rec... |
|
|
Update CME: Internal Medicine and Primary Care LiveStream Rebroadcast May 2022
This livestreamed conference (7.30 a.m. May 12 - 1.15 p.m. May 15) organized by the American Medical Forum will be a rebroadcast of the November 2021 conference. Eminent speakers from The University of Chicago, Rush University, and Northwestern University will present the most advanced clinical guidelines. The course also offers pre-recorded Q&A sessions. At the conclusion, participants will be able to incorporate the most up-to-date treatment strategies to general chronic medical conditions i... |
|
|
Update CME: Internal Medicine and Primary Care Livestream Rebroadcast April 2022
This livestreamed conference (7.30 a.m. April 7 - 1.15 p.m. April 10) organized by the American Medical Forum will be a rebroadcast of the November 2021 conference. Eminent speakers from The University of Chicago, Rush University, and Northwestern University will present the most advanced clinical guidelines. The course also offers pre-recorded Q&A sessions. At the conclusion, participants will be able to incorporate the most up-to-date treatment strategies to general chronic medical condition... |
|
|
Update CME: Internal Medicine and Primary Care Livestream Rebroadcast March 2022
This livestreamed conference (7.30 a.m. March 17 - 1.15 p.m. March 20) organized by the American Medical Forum will be a rebroadcast of the November 2021 conference. Eminent speakers from The University of Chicago, Rush University, and Northwestern University will present the most advanced clinical guidelines. The course also offers pre-recorded Q&A sessions. At the conclusion, participants will be able to incorporate the most up-to-date treatment strategies to general chronic medical conditio... |
|
|
Update CME: Internal Medicine and Primary Care Livestream Rebroadcast February 2022
This livestreamed conference (7.30 a.m. February 24 - 1.15 p.m. February 27) organized by the American Medical Forum will be a rebroadcast of the November 2021 conference. Eminent speakers from The University of Chicago, Rush University, and Northwestern University will present the most advanced clinical guidelines. The course also offers pre-recorded Q&A sessions. At the conclusion, participants will be able to incorporate the most up-to-date treatment strategies to general chronic medical co... |
|
|
Modernizing Care of Patients With BCC: Changes in Management Approaches
Utilize an interdisciplinary approach to identify patients with advanced BCC and apply expert guidance and clinical guidelines to determine the best treatment pathway for individual patients.
Identify patients with advanced BCC who have failed or cannot tolerate hedgehog inhibitor therapy and utilize an interdisciplinary approach to assess treatment options, including PD-1 inhibitors, and develop a plan to prevent/manage treatment-associated adverse events.
|
|
|
Diabetes Update 2022 - LIVE STREAMING
This highly rated Harvard Medical School CME course offers practical strategies to address the medical and systemic challenges to optimal care and updates that ensure you can deliver state-of-the-art care for your patients with diabetes.
PROGRAM HIGHLIGHTS
This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.
• Expert guidance to design comprehensive treat... |
|
|
41st Annual Cardiothoracic Surgery Symposium (CREF 2022)
The 41st Annual Cardiothoracic Surgery Symposium (CREF 2022) offers cutting-edge presentations, interactive discussions and debates, hands-on workshops, and extracurricular education on topics related to cardiac surgery, cardiopulmonary bypass, extracorporeal perfusion, and extracorporeal life support. It offers Category 1 CME & CEU credits, meeting the specific educational needs of CVOR and CVICU teams: cardiac anesthesiologists, cardiac surgeons, advanced-practice providers, nurses, and perf... |
|
|
Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis Non-COPE
Target Audience
This online educational activity is directed towards general ophthalmologists and optometrists. Additional clinicians who may have the opportunity to diagnosis patients with neurotrophic keratitis will also be invited to participate.
Activity Overview
This video-based program is designed for health care professionals to explore the diagnosis and treatment of neurotropic keratitis (NK) through a unique perspective, putting the patient voice front and center. A patient w... |
|
|
Advances in™ Dry Eye Disease - The Future of Treatment for Patients with Meibomian Gland Dysfunction-Associated DED
Target Audience
This online educational activity is directed toward ophthalmologists, optometrists and other healthcare professionals who would be involved in dry eye disease care, such as PCPs, NPs and PAs.
Program Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED), with a forward-looking perspective on how new and novel agents may impact... |
|
|
Real-World Experience in Diagnosing and Managing PNH in Special Patient Populations
In a “how I do it” clinical commentary, Dr. Jamile Shammo and Dr. Ilene Weitz share their real-world experience in the diagnosis and management of PNH in special patient populations. This case-based activity includes clinical scenarios and treatment strategies to improve patient outcomes. |
|
|
Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis
Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C review best practices to facilitate successful therapeutic interventions with hemophilia A Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C
|
|
|
Respiratory Syncytial Virus: Protecting Older Adults at Risk for Serious Complications
Target Audience
This activity was developed for family practice physicians, primary care physicians, nurse practitioners, nurses and other healthcare professionals who care for older adults.
Program Overview
Each year, respiratory syncytial virus (RSV) infects up to 10% of older adults who live in congregate settings and predisposes to an increased risk for hospitalization and death, particularly in those with comorbid cardiopulmonary disease. Stefan Gravenstein, MD, MPH, compares the... |
|
|
Continuity in Care®: Best Practices in Immunoglobulin Therapy—Improving Quality of Life for Patients With Primary Immunodeficiency
Target Audience
These activities are intended for an audience of immunologists, infusion nurses, pediatricians, nurse practitioners, physician assistants, and pharmacists involved in the dispensing and administration of immunoglobulin replacement therapy (IgG) for patients with PI.
Program Overview
This video-based program is designed to help health care professionals explore treatment options for patients with primary immunodeficiency (PI) through a unique perspective: putting the pa... |
|
|
Understanding and Managing NTM-Lung Disease
This educational module focuses on nontuberculous mycobacterial (NTM) lung disease, its diagnosis, treatment, and patient management. An expert panel discussion, animations, and a patient’s story are highlighted within this education. This EXPLORE module has highly interactive and engaging online content, designed to allow learners to choose their own learning course. |
|
|
Neurology in Clinical Practice
The Neurology in Clinical Practice conference is an annual Mayo Neurology course that brings together a multidisciplinary faculty from across our three campuses in Rochester, MN; Jacksonville, FL; and Scottsdale, AZ. The course format consists of case-based presentations in the morning and is reinforced with optional afternoon workshops. This program will explore common neurology clinical problems and is intended to provide a comprehensive, evidence-based review of recent advances in the evalu... |
|
|
PER Postgame™: Protecting Patients with MS from COVID-19—Exploring the Latest in Prevention and Immunosuppressive Treatment Strategies
Target Audience
This educational activity is directed toward community neurologists, neuroimmunologists, MS specialists, specialty nurse practitioners, physician assistants, registered nurses, pharmacists, and other members of the MS care team.
Activity Overview
The COVID-19 pandemic is an unprecedented health care crisis with disproportionate impact on immunocompromised populations. There are unanswered questions and a lack of understanding about the immune response to SARS-CoV-2 vaccine... |
|
|
Medical Crossfire®: Personalized Regimens for Managing Hemophilia A: Selecting an Optimal Recombinant FVIII Agent
Target Audience
This online educational activity is directed toward hematologists, primary care clinicians, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the management of hemophilia.
Activity Overview
Over the past 20 years, substantial advances in the treatment of hemophilia A have allowed patients to take greater control of their disease. The primary goals of hemophilia A treatment are to prevent bleeding episodes, reduce lon... |
|
|
Improving Selection and Utilization of Continuous Glucose Monitors (CGM) for People with Diabetes
Self-monitoring of blood glucose (BG) levels is critical to daily self-management for people with diabetes. Studies have shown that intensive insulin regimens and BG control corresponded with better glycemic control have resulted in a significant decrease in the microvascular complications of diabetes. Because CGM is still an evolving technology, both clinicians and patients would benefit from engaging, interactive, and evidence-based education to improve the utilization of these tools. |
|